Catherine Lhommé

Malignant effusions and immunogenic tumour-derived exosomes

Fabrice André, Noël E.C. Schartz, Mojgan Movassagh et al. · The Lancet · 2002 · 934 citations

Exosomes, Pathology, Extracellular Microvesicles +4

Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial

Bradley J. Monk, Andrés Poveda, Ignace Vergote et al. · The Lancet Oncology · 2014 · 304 citations

Oncology, Placebo-controlled Phase 3, Metronomic Therapy +8

Lymph Node Involvement in Epithelial Ovarian Cancer: Analysis of 276 Pelvic and Paraaortic Lymphadenectomies and Surgical Implications

Philippe Morice, F. Joulie, S. Camatte et al. · Journal of the American College of Surgeons · 2003 · 275 citations

Kidney Diseases Associated With Anti-Vascular Endothelial Growth Factor (VEGF)

Hassan Izzedine, Bernard Escudier, Catherine Lhommé et al. · Medicine · 2014 · 170 citations · Full text

Antimüllerian hormone as a serum marker of granulosa cell tumors of the ovary: Comparative study with serum α-inhibin and estradiol

Rodolfo A. Rey, Catherine Lhommé, Isabelle Marcillac et al. · American Journal of Obstetrics and Gynecology · 1996 · 155 citations

Antimüllerian Hormone, Endocrine Oncology, Female Infertility +12